Rui Avelar - Chief Medical Officer & Head of Research and Development at Evolus, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer & Head of Research and Development
Stock Symbol
EOLS on Nasdaq
All Insider Reports
All Insider Reports

Rui Avelar - trading volume in the past year for Evolus, Inc.

Holdings reported by Rui Avelar for Evolus, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 369K $4.69M $12.72 May 10, 2024 Direct
Performance Restricted Stock Units 17.6K $231K $13.14 Feb 7, 2024 Direct Common Stock
Stock Option (Right to Buy) 47.3K Feb 7, 2024 Direct Common Stock

Transactions reported by Rui Avelar for Evolus, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.